Drawing for CENCORA

USPTO serial 97765135

CENCORA

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
GRYGIEL, JONATHAN C
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with CENCORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anita B. Polott

Anita B. Polott MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
044Medical analysis services, namely, medical diagnostic testing, monitoring and reporting in the field of human disease treatment; providing medical information, namely, providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices being the specific diagnosis, line of therapy, stage of disease and regimen information; providing clinical and home health care services, namely, providing medical and healthcare information relating to therapeutic properties of pharmaceuticals; providing medical and healthcare counseling to patients in the field of administration of medications; providing medical and health clinical services and home health care services; providing medical care information; Health care services, namely, providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; providing medical, health and veterinary information services for the pharmaceutical and medical sectors; providing information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the pharmaceutical and medical sectors; providing medical and health counseling and pharmaceutical advice services related to workplace and personnel health; healthcare services; services of providing medical and healthcare information on medical substances; medical and healthcare consulting, namely, analyzing and reporting of discussions about human disease treatment; medical services in the nature of administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable medical, health, veterinary, pharmaceutical and medical biotechnical information and analysis about legislative regulatory developments in the field of healthcare; remote healthcare and telemedicine services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; remote healthcare and telemedicine services, namely, providing patients with health information relating to their medical condition; beauty and health care consulting services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; providing information on health and nutrition in the field of animal management; providing a website featuring information to retail customers of pharmacies over a global computer network with regard to health, wellness and pharmacy news; providing information, news and commentary in the field of current events relating to the healthcare industry and healthcare legislation and regulation; providing on-line information, news and commentary in the field of health and wellness relating to healthy diets and activities for male and female infants, children, teenagers, adults and seniors and to illnesses and treatments affecting them; pharmaceutical consultation; providing medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2026EX3GSOU EXTENSION 3 GRANTED—
Jul 21, 2026EXT3SOU EXTENSION 3 FILED—
Jul 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2026EX2GSOU EXTENSION 2 GRANTED—
Feb 9, 2026EXT2SOU EXTENSION 2 FILED—
Feb 9, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 12, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 11, 2025EX1GSOU EXTENSION 1 GRANTED—
Aug 11, 2025EXT1SOU EXTENSION 1 FILED—
Aug 11, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 17, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 19, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 19, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Apr 18, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 16, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 16, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 23, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023DOCKASSIGNED TO EXAMINER—
Oct 18, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 26, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance